Access all versions of the report here:
RCR14: Gimsilumab – Version 3: May 2021
RCR14: Gimsilumab – Version 2: September 2020
RCR14: Gimsilumab – Version 1: August 2020
Note: From October 2020, the update of the literature search for Gimsilumab will be done on a bi-monthly basis. In case new evidence is identified in the bi-monthly literature search, this RCR will be updated and my be put back into the monthly process.
This website was produced under the Third EU Health Programme through a service contract with the European Health and Digital Executive Agency (HaDEA) acting under the mandate from the European Commission. The information and views set out in this website are those of the author(s) and do not necessarily reflect the official opinion of the Commission/Executive Agency. The Commission/Executive Agency do not guarantee the accuracy of the data included in this website. Neither the Commission/Executive Agency nor any person acting on the Commission’s/Executive Agency’s behalf may be held responsible for the use which may be made of the information contained therein.
©2021 EUnetHTA All rights reserved.
